# A Study to Evaluate the Efficacy and Safety of CJ-30001 and CJ-30002 in Type 2 Diabetes Mellitus Patients

> **NCT01370707** · PHASE3 · COMPLETED · sponsor: **HK inno.N Corporation** · enrollment: 187 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Metformin
- **DRUG:** CJ-30001/CJ-30002

## Key facts

- **NCT ID:** NCT01370707
- **Lead sponsor:** HK inno.N Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 187 (ACTUAL)
- **Last updated:** 2013-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01370707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01370707, "A Study to Evaluate the Efficacy and Safety of CJ-30001 and CJ-30002 in Type 2 Diabetes Mellitus Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01370707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*